Cegedim Sa · EURONEXT:ALCGM

Cegedim Sa — FY2014 Earnings Presentation

38 slides from Cegedim Sa's earnings presentation, Mar 27, 2015

  1. Slide 1: FY 2014 Earnings

    FY 2014 EARNINGS SFAF Meeting Friday 27th, March 2015

  2. Slide 2: Safe Harbor Statement

    SAFE HARBOR STATEMENT This presentation contains forward-looking statements (made pursuant to the safe harbour provisions of the Private Securities Litigation Reform Act of 1995). By their nature, forward-looking statements involve risk and uncertainty. Forward-looking statements represent the compa

  3. Slide 3: IMS Health transaction and IFRS 5 reporting

    On October 20, 2014, Cegedim, announced that a definitive purchase agreement has been executed for its CRM and Strategic Data division with IMS Health Inc. The transaction will take effect in in early 2015 second quarter, post publication of this document. Consequently the 2014 Financial Statements

  4. Slide 4: Agenda

    AGENDA.  Business & Strategy Review  2014 Financial Situation 4

  5. Slide 5: Business & Strategy Review

    Business & Strategy Review Jean-Claude Labrune

  6. Slide 6: Transforming Cegedim

    Transforming Cegedim 2014 Earnings – March 2015 6

  7. Slide 7: Changes in Drug Promotion

    Changes in Drug Promotion 2014 Earnings – March 2015 7

  8. Slide 8: Changes in Software for Healthcare Professionals

    Changes in Software for Healthcare Professionals 2014 Earnings – March 2015 8

  9. Slide 9: Changes in Insurance Landscape

    Changes in Insurance Landscape 2014 Earnings – March 2015 9

  10. Slide 10: Changes in E-business and HR Management and RNP Activities

    Changes in E-business and HR Management and RNP Activities 2014 Earnings – March 2015 10

  11. Slide 11: A Strong Portfolio of Products Well-Aligned with Cegedim Areas of Focus

    A Strong Portfolio of Products Well-Aligned with Cegedim Areas of Focus 2014 Earnings – March 2015 11

  12. Slide 12: Conclusion

    Conclusion 2014 Earnings – March 2015 12

  13. Slide 13: The Market is Recognizing Our Future Growth Potential

    The Market is Recognizing Our Future Growth Potential Share Price Performance 2014 Earnings – March 2015 13

  14. Slide 14: 2014 Financial Situation

    2014 Financial Situation Pierre Marucchi

  15. Slide 15: Key Financial Accomplishments

    Key Financial Accomplishments 2014 Earnings – March 2015 15

  16. Slide 16: 2014 Consolidated P&L from Revenue to EBIT before special items

    2014 Consolidated P&L from Revenue to EBIT before special items 2014 Earnings – March 2015 16

  17. Slide 17: Significant Reduction in Currency and Seasonality Impact

    Significant Reduction in Currency and Seasonality Impact 2014 Earnings – March 2015 17

  18. Slide 18: Revenue Breakdown

    Revenue Breakdown 2014 Earnings – March 2015 18

  19. Slide 19: EBIT Before Special Items by Division in €m

    EBIT Before Special Items by Division in €m 2014 Earnings – March 2015 19

  20. Slide 20: 2014 Consolidated P&L from EBIT before special items to EPS

    2014 Consolidated P&L from EBIT before special items to EPS 2014 Earnings – March 2015 20

  21. Slide 21: 2014 Consolidated Earnings

    2014 Consolidated Earnings 2014 Earnings – March 2015 21

  22. Slide 22: Capex

    Capex We remain committed to our approach to capital deployment 2014 Earnings – March 2015 22

  23. Slide 23: 2014 Net Debt Change

    2014 Net Debt Change 2014 Earnings – March 2015 23

  24. Slide 24: 2014 Consolidated Balance Sheet

    2014 Consolidated Balance Sheet 2014 Earnings – March 2015 24

  25. Slide 25: Update on the transaction

    Update on the transaction 2014 Earnings – March 2015 25

  26. Slide 26: Next Steps on IMS Health Transaction

    Next Steps on IMS Health Transaction 2014 Earnings – March 2015 26

  27. Slide 27: The New Cegedim

    The New Cegedim 2014 Earnings – March 2015 27

  28. Slide 28: Robust Financial Structure

    Robust Financial Structure 2014 Earnings – March 2015 28

  29. Slide 29: Strategic Priorities

    Strategic Priorities 2014 Earnings – March 2015 29

  30. Slide 30: Outlook

    Outlook 2014 Earnings – March 2015 30

  31. Slide 31: Next Events

    Next Events 2014 Earnings – March 2015 31

  32. Slide 32: 2015 Financial Agenda

    2015 Financial Agenda 2014 Earnings – March 2015 32

  33. Slide 33: Annexes

    Annexes

  34. Slide 34: Cegedim at a Glance

    Cegedim at a Glance 2014 Earnings – March 2015 34

  35. Slide 35: Cegedim is Well-Positioned

    Cegedim is Well-Positioned 2014 Earnings – March 2015 35

  36. Slide 36: Revenue & Organic Growth Calculation

    Revenue & Organic Growth Calculation Healthcare Insurance & GERS Activities & YTD Décembre 2014 Revenue Professionals Services Reconciliation Group 2013 Revenue (a) 294 497 161 148 31 973 487 618 Impact of disposals 0 0 0 0 2013 Revenue before impact of disposals 294 497 161 148 31 973 487 618 Curre

  37. Slide 37: Key Figures by Divisions

    Key Figures by Divisions EBIT before special Revenue EBITDA in €m items 2014 2013 2014 2013 2014 2013 Healthcare professionals 295,6 295,5 31,1 35,4 52,9 59,7 Insurance and services 165,0 161,1 22,8 24,8 36,7 38,6 GERS Activities and Reconciliation 32,9 32,0 -4,4 -8,3 -2,7 -6,7 Total from continuing

  38. Slide 38: We welcome your questions and comments

    We welcome your questions and comments Jan Eryk UMIASTOWSKI Chief Investment Officer - Head of Investor Relations janeryk.umiastowski@cegedim.com

Cegedim — FY2014 Earnings Presentation on 6ix